SEI Investments
TLSI icon

SEI Investments’s TriSalus Life Sciences TLSI Stock Holding History

SEI Investments’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$137K Hold
31,809
– – ﹤0.01% 3127
2026
Q2 		$145K Sell
31,809
-37,061
-54% -$147K ﹤0.01% 3122
2026
Q1 		$275K Buy
+68,870
New +$337K ﹤0.01% 2850

Other funds holding TLSI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
White Pine Capital
White Pine Capital Bloomington, Minnesota $419M AUM 48.71% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

SEI Investments's TLSI Position: Q3 2026 in Review

SEI Investments held its TriSalus Life Sciences (TLSI) position steady in Q3 2026 at 31,809 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #3127.

SEI Investments first reported a position in TLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $275K in Q1 2026. 39 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • SEI Investments held 31,809 shares of TriSalus Life Sciences worth $137K as of Q3 2026.
  • SEI Investments left its TriSalus Life Sciences share count unchanged in Q3 2026.
  • TriSalus Life Sciences made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #3127 holding.
  • SEI Investments first reported a position in TriSalus Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • SEI Investments's TriSalus Life Sciences position peaked at $275K in Q1 2026.
  • 39 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.